pentobarbital will lower the level or impact of diazepam buccal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Solid or reasonable CYP3A4 inducers may increase charge of diazepam elimination; as a result, efficacy of diazepam might be decreased.
pentobarbital will minimize the level or influence of meloxicam by impacting hepatic enzyme CYP2C9/10 metabolism. Minimal/Importance Not known.
pentobarbital will reduce the level or effect of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Use of naloxegol with robust CYP3A4 inducers is just not advisable
fentanyl intranasal and pentobarbital each maximize sedation. Prevent or Use Alternate Drug. Limit use to clients for whom option remedy solutions are inadequate
pentobarbital will lower the level or effect of bazedoxifene/conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lessen the extent or outcome of tamoxifen by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Observe.
fentanyl transdermal and pentobarbital both enhance sedation. Prevent or Use Alternate Drug. Restrict use to patients for whom alternate procedure possibilities are inadequate
pentobarbital will lower the extent or impact of ramelteon by impacting hepatic enzyme CYP2C9/ten metabolism. Minimal/Significance Unidentified.
If your buprenorphine dose is insufficient plus the CYP3A4 inducer can not be minimized or discontinued, changeover the client back again into a buprenorphine formulation that allows dose changes.
This drug may well interfere with the absorption of orally administered griseofulvin, decreasing its blood amounts; effects of blood degree reduction mysterious; preferable to prevent concomitant administration of those drugs
fentanyl transdermal and pentobarbital both boost sedation. Prevent or Use Alternate Drug. Restrict use to patients for whom substitute treatment method alternatives are inadequate
pentobarbital will reduce the extent or influence of ondansetron by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. No dosage adjustment for ondansetron is usually recommended for clients on click here these drugs.
pentobarbital will lessen the level or result of propafenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.
pentobarbital will decrease the level or outcome of nitrendipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.